Restriction enzyme Xba I efficiently cleaves and linearizes template plasmid DNA and prepares it for downstream applications such as mRNA in vitro synthesis. Developed antibiotic-free and Animal-Origin-Free (AOF), Roche CustomBiotech Xba I provides the quality, scale and performance you need for manufacturing templates for mRNA therapeutics and vaccines.
We have designed our manufacturing process from the master cell bank to final QC-release to exclude or minimize potential contaminants, thereby reducing overall process risk and simplifying procedures for regulatory approval.
